ReAlta Life Sciences, Inc.
7 private offerings reported to the SEC on Form D since 2016, $94.3M sold in all. Biotech, Virginia.
- Form D offerings: 7
- Reported sold: $94.3M
- Newest: May 21, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| May 21, 2025 | — | $29.9M | $30.0M | ReAlta Life Sciences, Inc.Biotech · Virginia | Not amended | 0001752530-25-000002 |
| May 21, 2025 | — | $25.0M | $25.0M | ReAlta Life Sciences, Inc.Biotech · Virginia | Not amended | 0001752530-25-000003 |
| May 21, 2025 | — | $12.0M | $12.0M | ReAlta Life Sciences, Inc.Biotech · Virginia | Not amended | 0001752530-25-000001 |
| Sep 13, 2023 | — | $22.5M | $22.5M | ReAlta Life Sciences, Inc.Biotech · Virginia | Not amended | 0001752530-23-000002 |
| Feb 19, 2020 | — | None yet | $2.0M | ReAlta Life Sciences, Inc.Pharma · Virginia | Not amended | 0001752530-20-000001 |
| Oct 28, 2019 | — | None yet | $12.0M | ReAlta Life Sciences, Inc.Pharma · Virginia | Not amended | 0001752530-19-000001 |
| Sep 12, 2018 | — | $4.8M | $12.0M | ReAlta Life Sciences, Inc.Pharma · Virginia | Not amended | 0001752530-18-000001 |
- Business address
- Norfolk, Va
- Incorporated in
- Delaware
- All SEC filings
- CIK 1752530 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR